The Filing Desk

Profound Medical vs Vivos Therapeutics

Profound Medical PROF · Vivos Therapeutics VVOS · Health Care Equipment

Vivos Therapeutics reported revenue of $17 million in fiscal 2025, about the same as Profound Medical's $16 million in fiscal 2025. Profound Medical's revenue grew 50.7% in its latest year, and Vivos Therapeutics' grew 16.1%. Profound Medical had an operating margin of -256.3%, against -114.0% at Vivos Therapeutics. Free cash flow was −$38 million at Profound Medical and −$18 million at Vivos Therapeutics.

Side by side

Profound MedicalVivos Therapeutics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$16M$17M
Revenue growth50.7%16.1%
Revenue growth a year, last 5 years17.1%5.8%
Gross margin70.8%60.4%
Operating margin−256.3%−114.0%
Net margin−264.4%−121.4%
Free cash flow−$38M−$18M
Free cash flow margin−238.4%−100.9%
Return on capital−304.9%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count22.1%104.7%
Last close$6.59$0.06
P/E at the last close——
Insider trades, last 12 months—bought $1.8 million, sold $0
Piotroski F-score5 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Profound MedicalVivos Therapeutics
Operating margin
Percent of revenue
Profound MedicalVivos Therapeutics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Profound MedicalVivos Therapeutics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Profound Medical and Vivos Therapeutics pages.